Structural basis for the substrate specificity of an S-formylglutathione hydrolase derived from Variovorax sp. PAMC 28711.

Biochem Biophys Res Commun

Research Unit of Cryogenic Novel Material, Korea Polar Research Institute, Incheon, 21990, Republic of Korea; Department of Polar Sciences, University of Science and Technology, Incheon, 21990, Republic of Korea. Electronic address:

Published: November 2022

AI Article Synopsis

  • S-Formylglutathione hydrolase (VaSFGH) is an enzyme that primarily breaks down S-formylglutathione but can also act on other thioester and ester compounds.
  • * Researchers discovered the VaSFGH gene in an Antarctic bacterium and characterized its protein, finding it works best on short-chain p-nitrophenyl esters.
  • * The study revealed the crystal structure of VaSFGH, showing limitations in its substrate-binding pocket that affect its ability to process larger substrates, which is valuable for future enzyme modifications for industrial applications.

Article Abstract

S-Formylglutathione hydrolase was originally known to catalyze the hydrolysis of S-formylglutathione to formate and glutathione. However, this enzyme has a broader esterase activity toward substrates containing thioester and ester bonds. In a previous study, we identified a new S-formylglutathione hydrolase (VaSFGH) gene in the Antarctic bacterium Variovorax sp. PAMC 28711, and recombinant VaSFGH protein was purified and characterized. Previous enzyme activity assays showed that VaSFGH has high activity, especially toward short-chain p-nitrophenyl esters (C2-C4). In this study, we determined the crystal structure of substrate-free VaSFGH at a resolution of 2.38 Å. In addition, p-nitrophenyl ester-bound VaSFGH structure models were generated by molecular docking simulations to obtain structural evidence of its substrate specificity. Comparative structural analysis of the apo-form and p-nitrophenyl ester-bound VaSFGH model structures revealed that large substrates could not bind inside the hydrophobic substrate-binding pocket because of the intrinsically static and relatively small substrate-binding pocket size of VaSFGH. This study provides useful information for further protein engineering of SFGHs for industrial use.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2022.09.008DOI Listing

Publication Analysis

Top Keywords

s-formylglutathione hydrolase
12
substrate specificity
8
variovorax pamc
8
pamc 28711
8
p-nitrophenyl ester-bound
8
ester-bound vasfgh
8
substrate-binding pocket
8
vasfgh
7
structural basis
4
basis substrate
4

Similar Publications

Structural basis for the substrate specificity of an S-formylglutathione hydrolase derived from Variovorax sp. PAMC 28711.

Biochem Biophys Res Commun

November 2022

Research Unit of Cryogenic Novel Material, Korea Polar Research Institute, Incheon, 21990, Republic of Korea; Department of Polar Sciences, University of Science and Technology, Incheon, 21990, Republic of Korea. Electronic address:

Article Synopsis
  • S-Formylglutathione hydrolase (VaSFGH) is an enzyme that primarily breaks down S-formylglutathione but can also act on other thioester and ester compounds.
  • * Researchers discovered the VaSFGH gene in an Antarctic bacterium and characterized its protein, finding it works best on short-chain p-nitrophenyl esters.
  • * The study revealed the crystal structure of VaSFGH, showing limitations in its substrate-binding pocket that affect its ability to process larger substrates, which is valuable for future enzyme modifications for industrial applications.
View Article and Find Full Text PDF

Objective: Salivary gland tumors (SGTs) show some aggressive and peculiar clinicopathological behaviors that might be related to the components of the tumor microenvironment, especially mesenchymal stem cells (MSCs)-associated proteins. However, the role of MSCs-related proteins in SGTs tumorigenesis is poorly understood. This study aimed to isolate and characterize MSCs from malignant and benign tumor tissues and to identify differentially expressed proteins between these two types of MSCs.

View Article and Find Full Text PDF

Activation of Esterase D by FPD5 Inhibits Growth of A549 Lung Cancer Cells via JAB1/p53 Pathway.

Genes (Basel)

April 2022

Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Science, Shandong University, Qingdao 266237, China.

Esterase D (ESD) is widely distributed in mammals, and it plays an important role in drug metabolism, detoxification, and biomarkers and is closely related to the development of tumors. In our previous work, we found that a chemical small-molecule fluorescent pyrazoline derivative, FPD5, an ESD activator, could inhibit tumor growth by activating ESD, but its molecular mechanism is still unclear. Here, by using RNA interference (RNAi), andco-immunoprecipitation techniques, we found that ESD suppressed the nucleus exportation of p53 through reducing the interaction between p53 and JAB1.

View Article and Find Full Text PDF

Esterase D stabilizes FKBP25 to suppress mTORC1.

Cell Mol Biol Lett

December 2021

Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Science, Shandong University, Qingdao, 266237, People's Republic of China.

Background: Esterase D (ESD) is a nonspecific esterase that detoxifies formaldehyde. Many reports have stated that ESD activity is associated with a variety of physiological and pathological processes. However, the detailed signaling pathway of ESD remains poorly understood.

View Article and Find Full Text PDF

A new activator of esterase D decreases blood cholesterol level through ESD/JAB1/ABCA1 pathway.

J Cell Physiol

June 2021

Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Science, Shandong University, Qingdao, P.R. China.

Excessively high cholesterol content in the blood leads to nonalcohol fatty liver disease (NAFLD) and arteriosclerosis. Although there are increasing publications and patent applications to lower blood cholesterol with small chemical molecules, limited effective drugs can be available in clinic. It is necessary to uncover new targets and drugs to alleviate high cholesterol.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!